Search IDVs

75F40126D00023

Indefinite Delivery Contract

Overview

Government Description
IDIQ for pharmaceutical products for cder research studies. Includes brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics, drug-device combination products, and contrast agents. Eo 14398
Awardee
Pricing
Fixed Price
Set Aside
None
Extent Competed
Competed Under Simplified Acquisition Procedures
Multiple / Single Award
Single Award
Who Can Use
Single Agency
Vehicle Ceiling
$4,000,000 (2% Used)
Analysis Notes
Direct Award $99,919.36 was obligated directly to this IDV and does not have an associated task order.
WE Pharma was awarded Indefinite Delivery Contract 75F40126D00023 (75F401-26-D-00023) by the FDA Office of Acquisition and Grant Services in September 2026. The IDC has a duration of 5 years and was awarded through solicitation Pharmaceutical Products for CDER Research Studies - IDIQ full & open with NAICS 325412 and PSC 6505 via simplified acquisition acquisition procedures with 2 bids received. To date, $99,919 has been obligated through this vehicle. The total ceiling is $4,000,000, of which 2% has been used.

Status
(Open)

Modified 9/11/26
Period of Performance
9/14/26
Start Date
9/14/31
Ordering Period End Date
0% Complete

Task Order Obligations
$99.9K
Total Obligated
$99.9K
Current Award
$99.9K
Potential Award
100% Funded

Award Hierarchy

Indefinite Delivery Contract

75F40126D00023

Contracts

0

Subcontracts

0

Opportunity Lifecycle

Procurement history for 75F40126D00023

Transaction History

Modifications to 75F40126D00023

People

Suggested agency contacts for 75F40126D00023

Competition

Number of Bidders
2
Solicitation Procedures
Simplified Acquisition
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
Yes

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
EWAMVJSFNK29
Awardee CAGE
7CN54
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Created By
hhsnsartain
Last Modified By
hhsnsartain
Approved By
hhsnsartain

Legislative

Legislative Mandates
None Applicable
Awardee District
NC-02
Senators
Thom Tillis
Ted Budd
Representative
Deborah Ross
Last Modified: 9/11/26